Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| B. Bal | M | 61 | 12 years | |
| John Caloz | M | 72 | 17 years | |
| Jeffrey Church | M | 67 | 14 years | |
| Michael Tardugno | M | 73 | 17 years | |
| Richard Danzig | M | 80 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 23 years |
| Frederick Fritz | M | 73 | 13 years | |
| Jeffrey White | M | 70 | 10 years | |
| David Truetzel | M | 67 | 14 years | |
| David O’Brien | M | 59 | 10 years | |
| Khursheed Anwer | M | 64 | 10 years | |
| Felix Kratz | M | - | 10 years | |
| Sarah Marshall | F | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Cooper | M | 65 | 15 years | |
| David Hallal | M | 57 | 10 years | |
| Joseph A. Madri | M | 80 | 22 years | |
| David Brennan | M | 70 | 7 years | |
| Steven Kriegsman | M | 82 | 20 years | |
| Jaisim Shah | M | 63 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 6 years |
| Kevin J. Ontiveros | M | 63 | 3 years | |
| Mark Reynolds | M | 62 | 14 years | |
| Melvin Booth | M | 79 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 years |
| Spencer J. Volk | M | - | 4 years | |
| Yim-Pan Cheung | M | 77 | 24 years | |
| Laurence Jay Korn | M | 74 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 16 years |
| David W. Keiser | M | 72 | 16 years | |
| Lawrence Olanoff | M | 72 | 1 years | |
| Eric Kenneth Olson | M | 60 | 7 years | |
| William A. Haseltine | M | 79 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Anthony P. Deasey | M | 74 | 7 years | |
| Louis J. Ignarro | M | 83 | 20 years | |
| Ty Lombardi | M | 51 | 2 years | |
| H. Watkins | M | 71 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
| Kory Wentworth | M | 45 | 9 years | |
| Verle D. Blaha | M | - | 1 years | |
| John Leone | M | 77 | 9 years | |
| John Tattory | M | 58 | 12 years | |
| Herbert H. McDade | M | 97 | 15 years | |
| Lisa Lejuwaan | F | - | - | |
| John C. King | M | 49 | 9 years | |
| Alberto R. Martinez | M | 74 | 10 years | |
| Ann Margaret Veneman | F | 74 | - | |
| William Keller | M | 75 | 6 years | |
| Gilles Gallant | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Jack Mollen | M | 73 | 7 years | |
| Curran Simpson | M | 62 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 9 years |
| Mark Day | M | 52 | 2 years | |
| Christian Stambach | M | 54 |
Centerpulse AG
 Centerpulse AG Medical SpecialtiesHealth Technology Centerpulse AG was a medical technology group, which served the reconstructive joint, spinal and dental implant markets. Its subsidiaries developed, produced and distributed medical implants and biological materials for orthopedic, spinal and dental markets worldwide. The product array included artificial joints, dental implants, spinal implants and instrumentation. The company was headquartered in Zurich, Switzerland.
Sulzer Medica
| 1 years |
| Pok Yu Chow | M | 71 | 16 years | |
| Chad Lewis | M | - | - | |
| William W. Freimuth | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Mary Templeton | F | 78 | - | |
| Gordon G. Esplin | M | 56 | - | |
| Michael V. Greco | M | 53 | 11 years | |
| Russell Clayton | M | - | - | |
| Ben R. Shappley | M | - | - | |
| Stacey M. Ambrose | F | - | - | |
| Klaus Jenny | M | 82 |
University of St. Gallen
| 5 years |
| Reyn E. Gallacher | M | - | - | |
| Bryan McEntire | M | 71 | - | |
| Steven W. Zeiger | M | - | - | |
| Kevin L. Davis | M | 58 | - | |
| Joseph Rubinfeld | M | 91 | 14 years | |
| Henry Morgan | M | 103 | 24 years | |
| Bradley G. Lorimier | M | 78 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 years |
| Evan Myrianthopoulos | M | 59 | 9 years | |
| Christopher Coughlin | M | 71 | 7 years | |
| Robert C. Young | M | 84 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
| Richard Fritschi | M | 64 |
Sulzer Medica
| 4 years |
| Augustine Lawlor | M | 67 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
| Richard L. Wennekamp | M | 80 | - | |
| Marvin R. Selter | M | 95 | 11 years | |
| Gregory R. Liberman | M | 51 | - | |
| Larry L. Mathis | M | 80 | 10 years | |
| Benjamin S. Levin | M | 46 | 12 years | |
| W. Amick | M | 81 | 9 years | |
| Thomas Miller | M | 52 | 11 years | |
| Kathleen A. McGowan | F | 63 | 4 years | |
| George T. Jue | M | 71 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 1 years |
| Barry A. Labinger | M | 60 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
| Joseph M. Mahady | M | 71 | 8 years | |
| Rockford Norby | M | 88 | 18 years | |
| Andreas Rummelt | M | 66 | 11 years | |
| Jürgen Drews | M | 91 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 13 years |
| David Lopez | M | 65 | 11 years | |
| Argeris Karabelas | M | 71 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 11 years |
| Bruce Peacock | M | 72 | 11 years | |
| Tuan Ha-Ngoc | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Robert Hooper | M | 77 | 12 years | |
| Scott Peters | M | - | 8 years | |
| M. Burns | F | 66 | 4 years | |
| Marvin E. Rosenthale | M | 90 | 20 years | |
| Alvin S. Parven | M | 83 | 19 years | |
| Jay Moyes | M | 70 | 2 years | |
| James H. Davis | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 15 years |
| Douglas O. Ebersole | M | 68 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | 14 years |
| Daniel J. Levitt | M | 76 | 8 years | |
| Steven Ryder | M | 73 | 5 years | |
| Mittie Doyle | M | 59 | 3 years | |
| Rebecca Velez Frey | F | - | 5 years | |
| Romesh R. Subramanian | M | 58 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| Switzerland | 3 | 3.00% |
| United Kingdom | 0 | -.--% |
| Germany | 0 | -.--% |
| Canada | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Max E. Link
- Personal Network
